Methylphenidate and the risk of trauma

Pediatrics

Volumn 135, Issue 1, 2015, Pages 40-48

  Man, Kenneth K C ^a   Chan, Esther W ^a   Coghill, David ^c   Douglas, Ian ^d   Ip, Patrick ^b   Leung, Ling Pong ^e   Tsui, Matthew S H ^e   Wong, Wilfred H S ^b   Wong, Ian C K ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE;

ACCIDENT PREVENTION; ADOLESCENT; ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CONTROLLED STUDY; EMERGENCY CARE; FEMALE; HONG KONG; HUMAN; INJURY; MAJOR CLINICAL STUDY; MALE; RISK REDUCTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; COMPLICATION; EMERGENCY HEALTH SERVICE; HOSPITAL ADMISSION; RISK FACTOR; STATISTICS AND NUMERICAL DATA; WOUNDS AND INJURIES; YOUNG ADULT;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; MALE; METHYLPHENIDATE; PATIENT ADMISSION; RISK FACTORS; WOUNDS AND INJURIES; YOUNG ADULT;

EID: 84920440293     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2014-1738     Document Type: Article

References (43)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013
2. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. 2007;164(6):942-948
3. Brock SE, Jimerson SR, Hansen RL. Identifying, Assessing, and Treating ADHD at School. New York: Springer, US; 2009:49-78
4. National Institute for Health and Clinical Excellence. Attention deficit hyperactivity disorder: diagnosis and management of ADHD in children, young people and adults. Available at: http://publications.nice.org.uk/attention-deficithyperactivity-disorder-cg72. Accessed April 26, 2012
5. Garfield CF, Dorsey ER, Zhu S, et al. Trends in attention deficit hyperactivity disorder ambulatory diagnosis and medical treatment in the United States, 2000-2010. Acad Pediatr. 2012;12(2): 110-116
6. Brault MC, Lacourse É. Prevalence of prescribed attention-deficit hyperactivity disorder medications and diagnosis among Canadian preschoolers and school-age children: 1994-2007. Can J Psychiatry. 2012;57(2):93-101
7. McCarthy S, Wilton L, Murray ML, Hodgkins P, Asherson P, Wong IC. The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care. BMC Pediatr. 2012;12:78
8. Wong IC, Murray ML, Camilleri-Novak D, Stephens P. Increased prescribing trends of paediatric psychotropic medications. Arch Dis Child. 2004;89(12):1131-1132
9. Man KK, Ip P, Hsia Y, Chan EW, Chui CS, Lam MP, Wong WH, Chow CB, Yung A, Wong IC. Attention-deficit/ hyperactivity disorder (ADHD) drug prescribing trend is increasing among school-aged children and adolescents. J Atten Disord. 2014
10. Ertan C, Özcan OO, Pepele MS. Paediatric trauma patients and attention deficit hyperactivity disorder: correlation and significance. Emerg Med J. 2012;29(11): 911-914
11. Hoare P, Beattie T. Children with attention deficit hyperactivity disorder and attendance at hospital. Eur J Emerg Med. 2003;10(2):98-100
12. Manor I, Gutnik I, Ben-Dor DH, et al. Possible association between attention deficit hyperactivity disorder and attempted suicide in adolescents - a pilot study. Eur Psychiatry. 2010;25(3): 146-150
13. Cuffe SP, Moore CG, McKeown R. ADHD and health services utilization in the national health interview survey. J Atten Disord. 2009;12(4):330-340
14. De Ridder A, De Graeve D. Healthcare use, social burden and costs of children with and without ADHD in Flanders, Belgium. Clin Drug Investig. 2006;26(2): 75-90
15. Leibson CL, Katusic SK, Barbaresi WJ, Ransom J, O'Brien PC. Use and costs of medical care for children and adolescents with and without attentiondeficit/ hyperactivity disorder. JAMA. 2001;285(1):60-66
16. Maxson RT, Lawson KA, Pop R, Yuma- Guerrero P, Johnson KM. Screening for attention-deficit/hyperactivity disorder in a select sample of injured and uninjured pediatric patients. J Pediatr Surg. 2009; 44(4):743-748
17. Leibson CL, Barbaresi WJ, Ransom J, et al. Emergency department use and costs for youth with attention-deficit/ hyperactivity disorder: associations with stimulant treatment. Ambul Pediatr. 2006;6(1):45-53
18. Clancy TA, Rucklidge JJ, Owen D. Roadcrossing safety in virtual reality: a comparison of adolescents with and without ADHD. J Clin Child Adolesc Psychol. 2006;35(2):203-215
19. Kemner JE, Lage MJ. Impact of methylphenidate formulation on treatment patterns and hospitalizations: a retrospective analysis. Ann Gen Psychiatry. 2006;5:5
20. Kemner JE, Lage MJ. Effect of methylphenidate formulation on treatment patterns and use of emergency room services. Am J Health Syst Pharm. 2006;63(4):317-322
21. Lage M, Hwang P. Effect of methylphenidate formulation for attention deficit hyperactivity disorder on patterns and outcomes of treatment. J Child Adolesc Psychopharmacol. 2004; 14(4):575-581
22. Durkin M, Chaudhari P, Slanton T, Kozma C. Comparison of health care costs and utilization among adults treated with long-acting medications for attentiondeficit/ hyperactivity disorder. J Manag Care Pharm. 2009;15(7):577
23. Cox DJ, Davis M, Mikami AY, Singh H, Merkel RL, Burket R. Long-acting methylphenidate reduces collision rates of young adult drivers with attentiondeficit/ hyperactivity disorder. J Clin Psychopharmacol. 2012;32(2):225-230
24. Barkley RA, Cox D. A review of driving risks and impairments associated with attention-deficit/hyperactivity disorder and the effects of stimulant medication on driving performance. J Safety Res. 2007;38(1):113-128
25. Marcus SC, Wan GJ, Zhang HF, Olfson M. Injury among stimulant-treated youth with ADHD. J Atten Disord. 2008;12(1): 64-69
26. Raman SR, Marshall SW, Haynes K, Gaynes BN, Naftel AJ, Stürmer T. Stimulant treatment and injury among children with attention deficit hyperactivity disorder: an application of the self-controlled case series study design. Inj Prev. 2013;19(3):164-170
27. van den Ban E, Souverein P, Meijer W, et al. Association between ADHD drug use and injuries among children and adolescents. Eur Child Adolesc Psychiatry. 2014;23(2):95-102
28. Chang Z, Lichtenstein P, D'Onofrio BM, Sjölander A, Larsson H. Serious transport accidents in adults with attention-deficit/hyperactivity disorder and the effect of medication: a population-based study. JAMA Psychiatry. 2014;71(3):319-325
29. Chiu SS, Lau YL, Chan KH, Wong WH, Peiris JS. Influenza-related hospitalizations among children in Hong Kong. N Engl J Med. 2002;347(26): 2097-2103
30. Chui CSL, Man KK, Cheng CL, et al. An investigation of the potential association between retinal detachment and oral fluoroquinolones: a self-controlled case series study. J Antimicrob Chemother. 2014;69(9):2563-2567
31. Rotheray KR, Aitken P, Goggins WB, Rainer TH, Graham CA. Epidemiology of injuries due to tropical cyclones in Hong Kong: a retrospective observational study. Injury. 2012;43(12):2055-2059
32. Chow CB, Leung M, Lai A, et al. Development of an electronic emergency department-based geo-information injury surveillance system in Hong Kong. Injury. 2012;43(6):739-748
33. Chan KL, Choi WM, Fong DY, Chow CB, Leung M, Ip P. Characteristics of family violence victims presenting to emergency departments in Hong Kong. J Emerg Med. 2013;44(1):249-258
34. The Hospital Authority Head Office/IT Department. Clinical Data Analysis and Reporting System (CDARS) User's Manual. 2nd ed. Hong Kong: The Hospital Authority Head Office 2003:3
35. Whitaker HJ, Farrington CP, Spiessens B, Musonda P. Tutorial in biostatistics: the self-controlled case series method. Stat Med. 2006;25(10):1768-1797
36. Hambidge SJ, Glanz JM, France EK, et al; Vaccine Safety Datalink Team. Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old. JAMA. 2006; 296(16):1990-1997
37. Douglas IJ, Evans SJ, Pocock S, Smeeth L. The risk of fractures associated with thiazolidinediones: a self-controlled case-series study. PLoS Med. 2009;6(9): e1000154
38. NICE. Attention Deficit Hyperactivity Disorder: Pharmacological and Psychological Interventions in Children, Young People and Adults. London, UK: The British Psychological Society and the Royal College of Psychiatrists; 2009
39. Wilson K, Hawken S. Drug safety studies and measures of effect using the selfcontrolled case series design. Pharmacoepidemiol Drug Saf. 2013; 22(1):108-110
40. Musonda P, Farrington CP, Whitaker HJ. Sample sizes for self-controlled case series studies. Stat Med. 2006;25(15): 2618-2631
41. Loo BP, Chow CB, Leung M, Kwong TH, Lai SF, Chau YH. Multidisciplinary efforts toward sustained road safety benefits: integrating place-based and peoplebased safety analyses. Inj Prev. 2013;19 (1):58-63
42. Leung GM, Tin KY, O'Donnell O. Redistribution or horizontal equity in Hong Kong's mixed public-private health system: a policy conundrum. Health Econ. 2009;18(1):37-54
43. Chan CW, Lam C, Lau J, et al. Attention Deficit/Hyperactivity Disorder in Children 2007 Position Paper. Hong Kong: The Hong Kong Society of Child Neurology & Developmental Paediatrics; March 2007